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ABSTRACT
BACKGROUND We examined the natural history of asthma in a primary care 
cohort of patients 10 years after the cohort was stratifi ed for asthma risk by 
responses to a questionnaire and bronchial hyperresponsiveness (BHR) testing.
METHODS Children and young adults who were born between 1967 and 1979 
within 1 of 4 affi liated family practices of the Nijmegen Department of Family 
Medicine, the Netherlands, were asked to participate in an asthma study in 1989. 
Of 926 patients available, 581 (63%) agreed to participate. Their family physi-
cians’ diagnoses of upper and lower respiratory tract disease and asthma were 
prospectively collected during the next 10 years and were analyzed.
RESULTS BHR or the presence of asthma symptoms at screening did not result 
in a signifi cantly disproportionate number of physician visits during the next 10 
years for 4 or more upper or lower respiratory tract infections when compared 
with patients who did not have these fi ndings at the beginning of the study. The 
presence of asthma symptoms correlated with an increased risk of an asthma 
diagnosis or allergic rhinitis in the group of patients who did not have asthma 
diagnosed at start of the study. One half of the known asthmatic patients at the 
onset of the study (21 of 44) had no further visits to their physicians for treatment 
of asthma during the next 10 years.
CONCLUSIONS In primary care, BHR testing has limited value in predicting subse-
quent respiratory tract disease for patients who have asthma diagnosed by a physi-
cian. The use of symptom questionnaires can be of clinical use in predicting asthma. 
Ann Fam Med 2004;2:110-115. DOI: 10.1370/afm.40.
INTRODUCTION
The current view of asthma is that of a chronic disease with periodic clinical exacerbations,1 a considerable change from our previous view of asthma as primarily episodic in nature. The highly variable nature 
of the clinical course of asthma makes it diffi cult for physicians and patients 
to know at any given time how much treatment is necessary and for how 
long. Asthma is, in essence, still quite different from other chronic diseases, 
such as hypertension or hyperlipidemia, the natural histories of which we 
now know quite well. The only information about the natural history of 
asthma is based on relatively few cohort studies.2,3 Information about the 
natural history of asthma in primary care populations remains a missing link 
between our biological knowledge of the disease and our clinical manage-
ment of it. Insight into the natural history is complicated by the level of 
undiagnosed asthma.4-6 Underdiagnosis of asthma is as much a problem for 
asthma research as it is for practitioners. Although much has been attributed 
to physicians’ problems in interpretation of clinical information, there are 
growing indications that patients’ reluctance to complain of symptoms or to 
adhere to follow-up visits also contribute to underdiagnosis.6
Longitudinal outcome studies of primary care patients with asthma 
should help us create this linkage and understand the developmental 
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epidemiology of asthma. Such studies require reason-
able asthma defi nitions, stable primary care popula-
tions observed for prolonged periods, and—given 
the frequency of undiagnosed asthma—a population 
perspective. Most clinical studies of asthma have used 
a combination of bronchial hyperresponsiveness (BHR) 
testing and responses to respiratory questionnaires to 
assist with an asthma diagnosis. Use of these diagnos-
tic tools is consistent with recommendations from the 
American Thoracic Society,7 World Health Organiza-
tion, and National Heart, Lung and Blood Institute.8 
Others have used physician diagnosis as the standard. 
Long-term follow-up remains a problem, partly because 
diagnosed asthma frequently disappears later on. 
Whether asthma disappears as a consequence of the 
natural history of asthma, adherence by the patient to 
treatment, or another phenomenon is not well known.
To improve our knowledge of the natural history of 
asthma, we observed a primary care cohort of children 
and adolescents that had been screened 10 years earlier 
for respiratory tract signs and symptoms by Kolnaar et 
al.9,10 The objective of the current study was to clarify 
the natural history of respiratory tract complaints and 
asthma in primary care.
METHODS 
In 1989, a cohort of children and young adults from 
4 affi liated family practices in the Netherlands was 
identifi ed for an asthma study based on date of birth.9,10 
Given the structure of the Dutch health care system, 
this cohort refl ects the characteristics of the popula-
tion.11 The study of Kolnaar et al9,10 assessed the rela-
tion of early childhood respiratory tract morbidity and 
asthma in adolescence. For that reason, the study was 
confi ned to the 926 patients drawn from all the chil-
dren born in Continuous Morbidity Registration prac-
tices (addressed below) between 
1967 and 1979, and who were 
still registered with the practices 
in 1989. The study cohort did 
not differ from the original birth 
cohort in terms of respiratory 
tract morbidity, but patients were 
more often of lower social class.9 
From this group, 581 agreed to 
participate, and 551 (60%) were 
able to complete the testing and 
questionnaire satisfactorily for 
interpretation. Again, there were 
no essential differences between 
participants and nonparticipants 
with regard to respiratory tract 
morbidity. All participants were 
screened for asthma by a symptom questionnaire and 
BHR testing.4,9,10 The respiratory symptom questions 
used in this study are displayed in Table 1. This ques-
tionnaire was based on the children’s version of the 
respiratory symptom surveys of the British Medical 
Research Council and American Thoracic Society.12 
Patients were considered symptomatic if they answered 
”yes” to the questions 1, 3, 4, or 5 (Table 1).
Histamine challenge testing was assessed by the 
concise version of the European Respiratory Society 
standardized testing procedure.13 If the provocative con-
centration of histamine causing a 20% decline in forced 
expiratory volume (FEV1) was ≤8.0 mg/mL (PC20), the 
study participants were considered to have a positive 
BHR test. Details of this study have been previously 
described.10 At the conclusion of this 1989–1990 study, 
all participants and their families were informed of their 
results, and those with symptoms or evidence of BHR 
were advised to visit their family physician. 
No relation could be found between early child-
hood respiratory tract morbidity (mainly infections) 
and asthma, respiratory symptoms, or BHR testing 
results in 1989.9 There was a substantial undiagnosed 
frequency of asthma (10%),4 however, and we were 
intrigued by the high frequency of BHR (39%) in oth-
erwise healthy adolescents without symptoms.10 
Since 1967, 4 family practices associated with the 
University of Nijmegen in the southeast of The Neth-
erlands have been continuously collecting outpatient 
morbidity data from all the patients they serve, a pro-
cess now called the Nijmegen academic family practice 
research network Continuous Morbidity Registration 
(CMR).11,14 The CMR was the source of the population 
and morbidity data for this study. The CMR provides 
a database in which the physician diagnoses (morbid-
ity) for each episode of outpatient care are coded and 
recorded. Each patient has a unique identifi er number 
Table 1. Respiratory Questionnaire Items
Symptom Questions
Chronic cough 1.  Did you usually, at least 5 days per week, cough (when getting up or dur-
ing the day or night) during a period of at least 3 consecutive months?
Chronic phlegm 2.  Did you usually, at least 5 days a week, bring up phlegm (when getting up, 
or during the day, or at night) for at least 3 consecutive months?
Chronic cough 
with phlegm
3.  Have you coughed up phlegm, more than usually, for at least 3 consecu-
tive weeks in the last 12 months?
Wheezing 4.  Have you had wheezing in your chest in the last 12 months?
Tightness with 
wheezing
5.  Have you had attacks of tightness with wheezing in your chest (attacks of 
asthma) in the last 12 months?
Breathless, age 6.  Do you think that you get breathless more quickly than friends of your 
own age?
Breathless, upstairs 7.  Have you been breathless going upstairs or riding a bike at a normal pace 
at least once in the last 12 months?
Breathless, fl at 8.  If yes, have you been breathless when you walked on the fl at at a normal 
pace at least once in the last 12 months?
Smoking behavior 9. Do you smoke? Have you ever smoked, and did you stop smoking?
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assigned at the point of care to which the coded mor-
bidity is assigned, and this information is attached to 
other demographic data available for the patient. The 
physicians within the 4 practices meet regularly to dis-
cuss classifi cation and coding issues to assure accuracy. 
Confi dentiality is assured by having the identifi er codes 
available only at the physician offi ces. 
The Dutch health care system is ideally suited for this 
type of morbidity study because all patients are registered 
with a family physician, and all access to care must come 
through this physician. Family physicians’ records include 
information of diagnosis and treatment by any other 
physician to whom the patient may have been referred. 
The CMR database includes, therefore, all diagnoses 
made through specialist care; for this study, respiratory 
tract diagnoses were made by chest physicians, internists, 
and pediatricians in addition to family physicians. Nearly 
everyone is insured by a single payer source, and the 
population is relatively stable. These factors allow excel-
lent patient tracking and outstanding opportunities for 
studying disease longitudinally.
For this study, patient records were reviewed up to 
2000. All but 7 patients could be found for follow-up, 
and data were available for 323 (59%) patients for the 
full 10-year period.
At the end of the 10 years of follow-up care, we 
reviewed the records of cohort patient visits to their 
family physicians, looking for respira-
tory tract problems diagnosed by the 
physicians. The outcomes of the 1989-
1990 screening period (symptomatic 
vs asymptomatic, BHR positive vs 
BHR negative, and the combination 
of symptomatic and BHR positive vs 
asymptomatic and/or BHR negative) 
were related to CMR-recorded respi-
ratory tract morbidity from 1990 to 
2000. Patients who had asthma diag-
nosed by their family physician before the 1989–1990 
screening period were dealt with separately in the analy-
sis. The analysis used the 1989 respiratory tract status 
of the patients (respiratory symptoms and BHR) as the 
independent variables, and the 1990–2000 respiratory 
tract morbidity diagnosed by their family physicians as 
the dependent variable. We used the Cox proportional 
hazard analysis to calculate the hazard ratio for getting 
an asthma diagnosis.
RESULTS
Almost all 544 participants had at least 1 physician visit 
during the 10 years of the study. Fifty percent (272) of 
the population were women. The average age of the 
cohort at follow-up was 25 years for women and 24 
years for men. Asthma was diagnosed at one time or 
another in 63 of the 544 patients (11.6%), of which 44 
had asthma diagnosed at the onset of the study and 19 
had asthma diagnosed after 1989.
From Table 2 it is apparent that the chance of having 
asthma diagnosed is signifi cantly increased if patients 
are symptomatic or are of younger age. Remarkably, 
the chance is not signifi cantly increased if patients have 
BHR, and there is no difference by patient sex.
Table 3 relates the baseline symptoms and BHR 
fi ndings to subsequent upper and lower respiratory 
Table 2. Hazard Ratio for Getting an Asthma Diagnosis (N = 500)
Variable Hazard Ratio
95% Hazard Ratio 
Confi dence Limits P Value
Symptomatic* 3.414 1.386, 8.410    .008
Bronchial 
hyperresponsiveness
1.278 0.519, 3.148    .59 
Age 0.816 0.687, 0.969    .02
Male 1.230 0.499, 3.031    .65
* Symptomatic means ≥1 positive answer to the respiratory tract symptom questionnaire in 1989.
Table 3. Respiratory Tract Symptoms of 298 Active Patients Still in Practice Without an Asthma 
Diagnosis at Start of Study
Symptoms
BHR
No. (%)
Non-BHR
No. (%)
RR
(95% CI)
P 
Value
Symptomatic*
No. (%)
Asymptomatic
No. (%)
RR 
(95% CI)
P 
Value
>4 upper respiratory 
tract infections†
16 (13)      21 (12) 1.1 (0.6–2.3)       .70       10 (16) 27 (11)  1.5 (0.7–3.2)    .34
Lower respriatory 
tract infections‡
18 (15)      16 (9) 1.8 (0.9–3.6)       .10         6 (10) 28 (12)  0.8 (0.3–2.0)    .46
Allergic rhinitis 18 (15)      21 (12) 1.3 (0.7–2.6)       .45       16 (25) 23 (10)  3.1 (1.5–6.4)    .001
Asthma 8 (7)       8 (5) 1.5 (0.5–4.1)       .40         8 (13) 8 (3)  4.1 (1.5–11.5)    .01
Total 121 (100)    177 (100)       63 (100) 235 (100)
BHR = bronchial hyperresponsiveness; RR = relative risk; CI = confi dence interval. 
* ≥1 positive answer to the respiratory tract symptom questionnaire in 1989.
† Includes otitis media, infl uenza, acute sinusitis, and laryngitis diagnoses.
‡ Includes pneumonia and acute bronchitis.
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tract infections, allergic rhinitis, and asthma for the 
298 patients who were still active in the practices and 
did not have a diagnosis of asthma at the start of the 
study. It is apparent that those patients with BHR dif-
fered little from those with no BHR in the likelihood of 
having their physician diagnose upper or lower respira-
tory tract infections, allergic rhinitis, or asthma. Those 
who answered affi rmatively to 1 or more of the asthma 
questions in 1989 also did not differ greatly in their 
likelihood of subsequently visiting their physicians with 
respiratory tract infections. They did, however, have a 
signifi cantly higher chance of having asthma diagnosed 
(P = .01, relative risk [RR] = 4.1, 95% confi dence inter-
val [CI], 1.5–11.5) or an allergic rhinitis diagnosis (P = 
.001, RR = 3.1, 95% CI, 1.5–6.4). 
We compared the outcomes of those members of 
the cohort thought to be most at risk for respiratory 
tract problems, ie, those who had a positive BHR test 
and were symptomatic, with those who had a nega-
tive BHR test and were asymptomatic. The 2 groups 
did not appear to differ in the diagnoses of upper and 
lower respiratory tract infections. The absolute risk of 
an asthma diagnosis in this subgroup of symptomatic 
hyperresponders (n = 50), however, was 10% compared 
with 2.6% for those who did not have these character-
istics (P = .04).
DISCUSSION
This study shows that in this cohort of children and 
young adults, a single positive test for BHR has limited 
prognostic importance for subsequent respiratory tract 
illness, including asthma. Because this cohort contains 
a specifi c age-group, these results are not generalizable 
to a different age-group. Nevertheless, the prevalence 
of asthma of 20 in 1,000 in the study population is in 
the high-normal range of the Dutch adolescent primary 
care population,15,16 so the a priori likelihood of asthma 
is representative of the family practice setting. More 
than 50% of patients with asthma did not have asthma 
diagnosed by their family physician,4 which highlights 
the relevance of case fi nding.
The results of this study may mean that BHR test-
ing has limited ability to capture the disease accurately. 
We showed, however, that more than 1 positive answer 
to questions 1, 3, 4, or 5 on the respiratory symptom 
questionnaire does correlate with an increased diagno-
sis of asthma in the future.
This study was aimed at all children and adolescents 
in the (practice) population and consequently included 
those with mild and moderate respiratory symptoms. It 
therefore describes the natural history of asthma as an 
episodic disease for which most patients will have no 
major diffi culties into adulthood.
Despite the relatively nonspecifi c symptoms that 
characterize asthma, various asthma symptom question-
naires have been developed with validation studies to 
support their use.17-19 These studies found that ques-
tionnaires were better than BHR testing as screening 
tools for asthma. This study confi rmed these outcomes. 
The studies also found that the positive predictive 
value of symptoms for an asthma diagnosis or for sub-
sequent problems was limited. On the basis of our fi nd-
ings, we calculated a predictive value of 13%, which is 
in line with the low prognostic value reported by oth-
ers. We also found that those who had no symptoms 
gained little prognostic information from BHR testing. 
It appears that in the epidemiologic study of respiratory 
tract disease, BHR testing is most useful after respira-
tory symptoms have been assessed.
Respiratory tract infections, in particular viral infec-
tions, increase airway infl ammation and thus may pro-
voke or increase symptoms in patients with asthma.20,21 
For that reason, it might be expected that patients with 
asthma would visit their physician more often than 
nonasthmatic patients for respiratory tract infections. 
Our data, however, did not confi rm this expectation. 
BHR is a marker of airway infl ammation; for that rea-
son, we were particularly interested in the patients who 
were asymptomatic in 1989 for BHR. The lack of respi-
ratory tract episodes in the 10 years of follow-up make 
it improbable that in our cohort BHR heralded an early 
state of airway infl ammation, which might be an impor-
tant difference from the other studies.
In 1962, BHR was included in the already estab-
lished defi nition of asthma as a disease characterized 
by reversible airfl ow obstruction.22 A single BHR read-
ing seems insuffi cient, however, to yield much useful 
information. When we applied more stringent criteria 
to the defi nition of BHR by reducing the PC20 cutoffs 
for FEV1 to ≤4 mg/mL, ≤2 mg/mL, and ≤1 mg/mL, 
we obtained fewer hyperresponsive patients, but a 
larger percentage of those had physician-diagnosed 
asthma. Because severity of BHR appears to correlate 
with asthma and a poorer outcome,23 this fi nding is 
not surprising. In changing the diagnostic criteria, we 
improved the specifi city of these tests for an asthma 
diagnosis, but in exchange, we diminished the sensitiv-
ity of the test to detect asthma. Josephs et al24 found 
that PC20 measurements did not consistently correlate 
with exacerbations of asthma. Pattemore et al25 
believed that BHR testing could “not reliably or pre-
cisely separate asthmatics from nonasthmatics in the 
general community.” Salome et al26 studied BHR, respi-
ratory tract symptoms, and asthma in 2,363 Australian 
children and noted that the association between these 
parameters and asthma is signifi cant but incomplete. 
Britton and Tattersfi eld27 suggested that the validity of a 
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positive BHR test in the clinical diagnosis of asthma is 
limited. Rasmussen et al28 in their Odense Schoolchild 
Study showed that in 10 years of follow-up, those with 
asymptomatic BHR on exercise testing had a weakly 
associated increase in coughing and wheezing. Many 
other community studies have confi rmed the weak 
association between asymptomatic BHR and the subse-
quent development of asthma.29,30 Laprise and Boulet,31 
however, showed that patients with asymptomatic 
airway hyperresponsiveness had a greater increase in 
airway responsiveness and frequency of development of 
asthma symptoms than did normoresponsive patients. 
Zhong et al32 reported that 45% of asymptomatic stu-
dents with positive BHR tests developed asthma in the 
following 2 years. 
The strength of the CMR database is its complete-
ness and the reliability of its recorded morbidity data.33 
This study does not elucidate the qualitative experi-
ences of the cohort in regard to respiratory disease 
and has selected only to look at the morbidity of this 
group recorded by their physicians in the 10 years 
after testing. The number of cases of asthma in the 
community, however, is not well known to the family 
physician.4 Van den Boom et al34 showed in his primary 
care DIMCA study that a great many adults have con-
siderable respiratory tract diffi culties that they have not 
made known to their physician. This fi nding remains 
fascinating, because effective treatment of asthma is 
possible and from a physicians’ perspective desirable. 
By not telling physicians about their symptoms of 
asthma, patients hamper the implementation of such 
treatment. A qualitative study to explore the patient’s 
perspective is planned in a later phase of this study. 
We have found BHR testing does not help us a 
great deal with determining who will have problems 
and who will require an intervention. We did fi nd, 
however, that a positive answer to the asthma symptom 
questionnaire was associated with an increased risk of 
an asthma diagnosis in the future, which suggests that 
the use of an asthma symptom questionnaire does have 
clinical signifi cance. Until we better understand the 
natural history of asthma in primary care and fi nd bet-
ter ways of looking for and treating patients at most 
risk, we will need to continue to be cautious about its 
diagnosis and management.
CONCLUSIONS
The majority of those with diagnosed asthma or asth-
ma symptoms in primary care do not have continuous 
problems with the disease.
A single test for BHR has a relatively low predictive 
value for adverse respiratory tract outcome.
More than 1 positive answer to an asthma symptom 
questionnaire increases the chance for patients having 
asthma diagnosed in the future.
To read commentaries or to post a response to this article, see it 
online at http://www.annfammed.org/cgi/content/full/2/2/110.
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